A case of ROS1‐rearranged lung adenocarcinoma exhibiting pleural effusion caused by crizotinib

Reports of crizotinib‐induced pleural effusion in non‐small cell lung cancer (NSCLC) are limited. A 35‐year‐old Japanese woman was diagnosed with ROS1‐rearranged lung adenocarcinoma (primary left lower lobe, cT4N3M1c). Crizotinib was administered as first‐line therapy, and the primary and mediastina...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachi, Hiroaki, Nishino, Kengo, Nakaizumi, Taisuke, Kuramoto, Kenya, Shimizu, Kei, Yamamoto, Yusuke, Kobayashi, Keisuke, Ichimura, Hideo, Sakata, Akiko, Nawa, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327693/
https://www.ncbi.nlm.nih.gov/pubmed/32433811
http://dx.doi.org/10.1111/1759-7714.13496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327693/
https://www.ncbi.nlm.nih.gov/pubmed/32433811
http://dx.doi.org/10.1111/1759-7714.13496

Ejemplares similares